FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Cavallin-Ståhl

Research Profile

Geographic Areas

Sweden

Concepts & Ideas

Procedures

Disorders

Living Beings

Survivors

Chemicals & Drugs

Antineoplastic Agents

Co-author Network

Publications

TOP 3
Karin Rydström; Eva Cavallin-Ståhl; Patrik Edén; Mats Ehinger; Mats Jerkeman; Patrick Joost; Johan Linderoth
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Hege S Haugnes; Anna Laurell; Ulrika Stierner; Roy M Bremnes; Eva Cavallin-Ståhl; Olav Dahl; Gabriella Cohn-Cedermark
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Johanna Skoogh; Gunnar Steineck; Ulrika Stierner; Anders Wallin; Ulrica Wilderäng; Eva Cavallin-Ståhl; Margaret Gatz; Boo Johansson
Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Cavallin-Ståhl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Karin Rydström; Eva Cavallin-Ståhl; Patrik Edén; Mats Ehinger; Mats Jerkeman; Patrick Joost; Johan Linderoth
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Leukemia & lymphoma 2012;53(9):1764-8.
2012: Hege S Haugnes; Anna Laurell; Ulrika Stierner; Roy M Bremnes; Eva Cavallin-Ståhl; Olav Dahl; Gabriella Cohn-Cedermark
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Acta oncologica (Stockholm, Sweden) 2012;51(2):168-76.
2012: Johanna Skoogh; Gunnar Steineck; Ulrika Stierner; Anders Wallin; Ulrica Wilderäng; Eva Cavallin-Ståhl; Margaret Gatz; Boo Johansson
Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.
Acta oncologica (Stockholm, Sweden) 2012;51(2):185-97.
2011: Sven-Erik Olofsson; Torgrim Tandstad; Mats Jerkeman; Olav Dahl; Olof Ståhl; Olbjørn Klepp; Roy M Bremnes; Gabriella Cohn-Cedermark; Carl W Langberg; Anna Laurell; Arne Solberg; Ulrika Stierner; Rolf Wahlqvist; Hans Wijkström; Harald Anderson; Eva Cavallin-Ståhl
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):2032-9.
2011: Patrik Romerius; Aleksander Giwercman; Christian Moëll; Thomas Relander; Eva Cavallin-Ståhl; Thomas Wiebe; Christer Halldén; Yvonne Lundberg Giwercman
Estrogen receptor α single nucleotide polymorphism modifies the risk of azoospermia in childhood cancer survivors.
Pharmacogenetics and genomics 2011;21(5):263-9.
2011: Olof Ståhl; Heather A Boyd; Aleksander Giwercman; Morten Lindholm; Allan Jensen; Susanne Krüger Kjær; Harald Anderson; Eva Cavallin-Ståhl; Lars Rylander
Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries.
Journal of the National Cancer Institute 2011;103(5):398-406.
2011: P Romerius; Olof Ståhl; Christian Moëll; Thomas Relander; Eva Cavallin-Ståhl; Thomas Wiebe; Yvonne Lundberg Giwercman; Aleksander Giwercman
High risk of azoospermia in men treated for childhood cancer.
International journal of andrology 2011;34(1):69-76.
2010: Patrik Romerius; Olof Ståhl; Christian Moëll; Thomas Relander; Eva Cavallin-Ståhl; Helen Gustafsson; Kerstin Löfvander Thapper; Katarina Jepson; Marcello Spanò; Thomas Wiebe; Yvonne Lundberg Giwercman; Aleksander Giwercman
Sperm DNA integrity in men treated for childhood cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3843-50.
2010: Jakob Eberhard; Olof Ståhl; Gabriella Cohn-Cedermark; Eva Cavallin-Ståhl; Yvonne Giwercman; Hamideh Rastkhani; Lars Rylander; Malin Eberhard-Gran; Ulrik Kvist; Aleksander Giwercman
Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.
Journal of affective disorders 2010;122(3):260-6.
2009: Olof Ståhl; Jakob Eberhard; Eva Cavallin-Ståhl; Katarina Jepson; B Friberg; C Tingsmark; Marcello Spanò; Aleksander Giwercman
Sperm DNA integrity in cancer patients: the effect of disease and treatment.
International journal of andrology 2009;32(6):695-703.
2009: Patrik Romerius; Olof Ståhl; Christian Moëll; Thomas Relander; Eva Cavallin-Ståhl; Thomas Wiebe; Yvonne Lundberg Giwercman; Aleksander Giwercman
Hypogonadism risk in men treated for childhood cancer.
The Journal of clinical endocrinology and metabolism 2009;94(11):4180-6.
2009: Jakob Eberhard; Olof Ståhl; Gabriella Cohn-Cedermark; Eva Cavallin-Ståhl; Yvonne Giwercman; Lars Rylander; Malin Eberhard-Gran; Ulrik Kvist; Kerstin S Fugl-Meyer; Aleksander Giwercman
Sexual function in men treated for testicular cancer.
The journal of sexual medicine 2009;6(7):1979-89.
2008: Johan Linderoth; Patrik Edén; Mats Ehinger; Jeanette Valcich; Mats Jerkeman; Pär-Ola Bendahl; Mattias Berglund; Gunilla Enblad; Martin Erlanson; Göran Roos; Eva Cavallin-Ståhl
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
British journal of haematology 2008;141(4):423-32.
2008: Jakob Eberhard; Olof Ståhl; Magdalena Cwikiel; Eva Cavallin-Ståhl; Yvonne Giwercman; Eva Cecilia Salmonson; Aleksander Giwercman
Risk factors for post-treatment hypogonadism in testicular cancer patients.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(4):561-70.
2008: Mats Ehinger; Johan Linderoth; Birger Christensson; Birgitta Sander; Eva Cavallin-Ståhl
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.
American journal of clinical pathology 2008;129(4):630-8.
2008: Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
International archives of occupational and environmental health 2008;81(3):285-93.
2007: Johan Linderoth; Mats Ehinger; Mats Jerkeman; Pär-Ola Bendahl; Måns Akerman; Mattias Berglund; Gunilla Enblad; Martin Erlanson; Göran Roos; Eva Cavallin-Ståhl
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Leukemia & lymphoma 2007;48(9):1774-9.
2007: Johan Linderoth; Mats Ehinger; Måns Akerman; Eva Cavallin-Ståhl; Gunilla Enblad; Martin Erlanson; Mats Jerkeman
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
European journal of haematology 2007;79(2):146-9.
2006: Olof Ståhl; Jakob Eberhard; Katarina Jepson; Marcello Spano; Magdalena Cwikiel; Eva Cavallin-Ståhl; Aleksander Giwercman
Sperm DNA integrity in testicular cancer patients.
Human reproduction (Oxford, England) 2006;21(12):3199-205.
2006: Katarina Link; Christian Moëll; Kai Osterberg; Roger Persson; Palle Ørbaek; Stanislaw Garwicz; Eva Cavallin-Ståhl; Eva Marie Erfurth
Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
Clinical endocrinology 2006;65(5):617-25.
2005: Ola Lindén; Jan Kurkus; Michael Garkavij; Eva Cavallin-Ståhl; Michael Ljungberg; Rune Nilsson; Tomas Ohlsson; Bengt E B Sandberg; Sven-Erik Strand; Jan Tennvall
A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):457-66.
2005: Mattias Berglund; Ulf Thunberg; Rose-Marie Amini; Majlis Book; Göran Roos; Martin Erlanson; Johan Linderoth; Michael Dictor; Mats Jerkeman; Eva Cavallin-Ståhl; Christer Sundström; Suzanne Rehn-Eriksson; Carin Backlin; Hans Hagberg; Richard Rosenquist; Gunilla Enblad
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(8):1113-20.
2005: Ola Lindén; Cecilia Hindorf; Eva Cavallin-Ståhl; William A Wegener; David M Goldenberg; Heather Horne; Tomas Ohlsson; Lars Stenberg; Sven-Erik Strand; Jan Tennvall
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5215-22.
2004: Katarina Link; Christian Moëll; Stanislaw Garwicz; Eva Cavallin-Ståhl; Jonas Björk; Ulf Thilén; Bo Ahrén; Eva Marie Erfurth
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
The Journal of clinical endocrinology and metabolism 2004;89(10):5003-12.
2004: Aleksander Giwercman; Kristina B Lundin; Jakob Eberhard; Olof Ståhl; Magdalena Cwikiel; Eva Cavallin-Ståhl; Yvonne Lundberg Giwercman
Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2152-8.
2004: Mats Jerkeman; H Anderson; Michael Dictor; Stein Kvaløy; Måns Akerman; Eva Cavallin-Ståhl
Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Annals of hematology 2004;83(7):414-9.
2004: Jakob Eberhard; Olof Ståhl; Yvonne Lundberg Giwercman; Magdalena Cwikiel; Eva Cavallin-Ståhl; Kristina B Lundin; Per Flodgren; Aleksander Giwercman
Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.
Human reproduction (Oxford, England) 2004;19(6):1418-25.
2004: Olof Ståhl; Jakob Eberhard; Katarina Jepson; Marcello Spano; Magdalena Cwikiel; Eva Cavallin-Ståhl; Aleksander Giwercman
The impact of testicular carcinoma and its treatment on sperm DNA integrity.
Cancer 2004;100(6):1137-44.
2003: Jeanette Lundin; Hans Hagberg; Roland Repp; Eva Cavallin-Ståhl; Susanne Fredén; Gunnar Juliusson; Eija Rosenblad; Geir Tjønnfjord; Tom Wiklund; Anders Osterborg
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome.
Blood 2003;101(11):4267-72.
2003: Johan Linderoth; Mats Jerkeman; Eva Cavallin-Ståhl; Stein Kvaløy; Emina Torlakovic
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):722-8.
2003: Ursula Falkmer; Johannes Järhult; Peter Wersäll; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in skeletal metastases.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):620-33.
2003: Anita Gustavsson; Birgitta Osterman; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):605-19.
2003: Anita Gustavsson; Birgitta Osterman; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):589-604.
2003: Gertrud Berg; Erik Blomquist; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in brain tumours.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):582-8.
2003: Anders Widmark; Per Flodgren; Jan-Erik Damber; Sverker Hellsten; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in urinary bladder cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):567-81.
2003: Nina Einhorn; Claes Tropé; Mona Ridderheim; Karin Boman; Bengt Sorbe; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in ovarian cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):562-6.
2003: Nina Einhorn; Claes Tropé; Mona Ridderheim; Karin Boman; Bengt Sorbe; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in uterine cancer (corpus uteri).
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):557-61.
2003: Nina Einhorn; Claes Tropé; Mona Ridderheim; Karin Boman; Bengt Sorbe; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in cervical cancer (cervix uteri).
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):546-56.
2003: Lars Erik Rutqvist; Carsten Rose; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in breast cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):532-45.
2003: Hans Strander; Ingela Turesson; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in soft tissue sarcomas.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):516-31.
2003: Florin Sirzén; Elisabeth Kjellén; Sverre Sörenson; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in non-small cell lung cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):493-515.
2003: Bengt Glimelius; Henrik Grönberg; Johannes Järhult; Arne Wallgren; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in rectal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):476-92.
2003: Anders Ask; Maria Albertsson; Johannes Järhult; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in oesophageal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):462-75.
2003: Björn Zackrisson; Claes Mercke; Hans Strander; Johan Wennerberg; Eva Cavallin-Ståhl
A systematic overview of radiation therapy effects in head and neck cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):443-61.
2003: Christer Lindholm; Eva Cavallin-Ståhl; Jeanette Ceberg; Jan-Erik Frödin; Bo Littbrand; Torgil R Möller
Radiotherapy practices in Sweden compared to the scientific evidence.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):416-29.
2003: Ulrik Ringborg; David Bergqvist; Bengt Brorsson; Eva Cavallin-Ståhl; Jeanette Ceberg; Nina Einhorn; Jan-Erik Frödin; Johannes Järhult; Gunilla Lamnevik; Christer Lindholm; Bo Littbrand; Anders Norlund; Urban Nylén; Måns Rosén; Hans Svensson; Torgil R Möller
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions.
Acta oncologica (Stockholm, Sweden) 2003;42(5-6):357-65.
2002: Ola Lindén; Jan Tennvall; Cecilia Hindorf; Eva Cavallin-Ståhl; Karl-Johan Lindner; Tomas Ohlsson; Karin Wingårdh; Sven-Erik Strand
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
Acta oncologica (Stockholm, Sweden) 2002;41(3):297-303.
2000: Thomas Relander; Eva Cavallin-Ståhl; Stanislaw Garwicz; Anna-Maria Olsson; M Willén
Gonadal and sexual function in men treated for childhood cancer.
Medical and pediatric oncology 2000;35(1):52-63.
1999: Ola Lindén; Jan Tennvall; Eva Cavallin-Ståhl; L Darte; Michael Garkavij; K J Lindner; Michael Ljungberg; Tomas Ohlsson; Katarina Sjögreen; Karin Wingårdh; Sven-Erik Strand
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3287s-3291s.
1999: Mats Jerkeman; H Anderson; Eva Cavallin-Ståhl; Michael Dictor; H Hagberg; A Johnson; S Kaasa; Stein Kvaløy; Christer Sundström; Måns Akerman
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(9):1079-86.
1999: Mats Jerkeman; Bertil Johansson; Måns Akerman; Eva Cavallin-Ståhl; Ulf Kristoffersson; Felix Mitelman
Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas.
European journal of haematology 1999;62(3):184-90.
1998: Jan Liliemark; U Martinsson; Eva Cavallin-Ståhl; Erik Svedmyr; Anna Porwit; M Strömberg; Gunnar Juliusson
Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;30(5-6):573-81.
1997: Olbjørn Klepp; O Dahl; Per Flodgren; Ulrika Stierner; Anna-Maria Olsson; J Oldbring; S Nilsson; L Daehlin; M Tørnblom; R Småland; Hans Starkhammar; L Abramsson; Erik Wist; NK Raabe; T Edekling; Eva Cavallin-Ståhl
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(7):1038-44.
1997: P Bergström; Anders Johnsson; Eva Cavallin-Ståhl; T Bergenheim; Roger Henriksson
Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
European journal of cancer (Oxford, England : 1990) 1997;33(1):153-9.
1996: Anders Johnsson; P Höglund; A Grubb; Eva Cavallin-Ståhl
Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus.
Cancer chemotherapy and pharmacology 1996;39(1-2):25-33.
1996: B Osterman; Eva Cavallin-Ståhl; H Hagberg; O Linden; P Lenner
High-grade non-Hodgkin's lymphoma stage I. A retrospective study of treatment, outcome and prognostic factors in 213 patients.
Acta oncologica (Stockholm, Sweden) 1996;35(2):171-7.
1994: Anders Johnsson; C Olsson; H Anderson; Eva Cavallin-Ståhl
Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude mice.
Cytometry 1994;17(2):142-50.
1993: A Johnson; Eva Cavallin-Ståhl; H Anderson
Blood lymphocyte clonal excess in advanced non-Hodgkin's lymphoma. Relation to clinical data and prognosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):393-8.
1992: Anders Johnsson; E Brun; Måns Akerman; Eva Cavallin-Ståhl
Primary gastric non-Hodgkin's lymphoma. A retrospective clinico-pathological study.
Acta oncologica (Stockholm, Sweden) 1992;31(5):525-31.
1991: A Johnson; Eva Cavallin-Ståhl; H Anderson
Incidence and prognostic significance of blood lymphocyte clonal excess in localized non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):739-43.
1991: A Johnson; Eva Cavallin-Ståhl; Måns Akerman
The significance of B-clonal excess in peripheral blood in patients with non-Hodgkin's lymphoma in remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():99-105.
1987: Jan Tennvall; Eva Cavallin-Ståhl; Måns Akerman
Primary localized non-Hodgkin's lymphoma of the thyroid: a retrospective clinicopathological review.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1987;13(4):297-302.